GRANULES INDIA
Back to Balance Sheet
|
GRANULES INDIA Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹2,003 Cr | ₹2,082 Cr | ₹1,814 Cr | ₹1,642 Cr | ₹1,173 Cr |
What is the latest Total Current Liabilities ratio of GRANULES INDIA ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹2,003 Cr |
| Mar2024 | ₹2,082 Cr |
| Mar2023 | ₹1,814 Cr |
| Mar2022 | ₹1,642 Cr |
| Mar2021 | ₹1,173 Cr |
How is Total Current Liabilities of GRANULES INDIA Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,003 Cr | -3.80 | |
| Mar2024 | ₹2,082 Cr | 14.82 | |
| Mar2023 | ₹1,814 Cr | 10.47 | |
| Mar2022 | ₹1,642 Cr | 39.94 | |
| Mar2021 | ₹1,173 Cr | - | |
Compare Total Current Liabilities of peers of GRANULES INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GRANULES INDIA | ₹13,847.2 Cr | 1% | -4.7% | -1.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹382,694.0 Cr | -2.3% | -7.3% | -12.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,721.0 Cr | 0.8% | -5.8% | 4.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,016.0 Cr | 0.8% | 3.7% | 20.8% | Stock Analytics | |
| CIPLA | ₹106,946.0 Cr | 0.7% | -11.2% | -6.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,691.0 Cr | -1.4% | -3.8% | -1.3% | Stock Analytics | |
GRANULES INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GRANULES INDIA | 1% |
-4.7% |
-1.4% |
| SENSEX | -0.1% |
-2.9% |
7.5% |
You may also like the below Video Courses